Cargando…

First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus

Epstein-Barr virus (EBV) infects and activates resting human B lymphocytes, reprograms them, induces their proliferation, and establishes a latent infection in them. In established EBV-infected cell lines, many viral latent genes are expressed. Their roles in supporting the continuous proliferation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pich, Dagmar, Mrozek-Gorska, Paulina, Bouvet, Mickaël, Sugimoto, Atsuko, Akidil, Ezgi, Grundhoff, Adam, Hamperl, Stephan, Ling, Paul D., Hammerschmidt, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751056/ https://www.ncbi.nlm.nih.gov/pubmed/31530670 http://dx.doi.org/10.1128/mBio.01723-19

Ejemplares similares

Epstein–Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection
por: Mrozek-Gorska, Paulina, et al.
Publicado: (2019)

Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection
por: Akidil, Ezgi, et al.
Publicado: (2021)

Epstein-Barr virus inactivates the transcriptome and disrupts the chromatin architecture of its host cell in the first phase of lytic reactivation
por: Buschle, Alexander, et al.
Publicado: (2021)

Modulation of alternative splicing during early infection of human primary B lymphocytes with Epstein-Barr virus (EBV): a novel function for the viral EBNA-LP protein
por: Manet, Evelyne, et al.
Publicado: (2021)

Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus
por: Bouvet, Mickaël, et al.
Publicado: (2021)

Assessing the Efficacy of VLP-Based Vaccine against Epstein-Barr Virus Using a Rabbit Model
por: Reguraman, Narendran, et al.
Publicado: (2023)

SARS-CoV-2 and Epstein–Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization Tests
por: Roessler, Johannes, et al.
Publicado: (2023)

Micro RNAs of Epstein-Barr Virus Promote Cell Cycle Progression and Prevent Apoptosis of Primary Human B Cells
por: Seto, Eri, et al.
Publicado: (2010)

Epigenetic lifestyle of Epstein-Barr virus
por: Buschle, Alexander, et al.
Publicado: (2020)

Replication Compartments—The Great Survival Strategy for Epstein–Barr Virus Lytic Replication
por: Sugimoto, Atsuko
Publicado: (2022)

Epstein-Barr viral miRNAs inhibit antiviral CD4(+) T cell responses targeting IL-12 and peptide processing
por: Tagawa, Takanobu, et al.
Publicado: (2016)

Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease
por: Bollard, Catherine M., et al.
Publicado: (2004)

Immortalization of human lymphocytes by Epstein-Barr virus.
por: Miller, G.
Publicado: (1982)

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation
por: Murata, Takayuki, et al.
Publicado: (2021)

Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma
por: Lee, Jae Myun, et al.
Publicado: (2011)

Strategies of Epstein-Barr virus to evade innate antiviral immunity of its human host
por: Albanese, Manuel, et al.
Publicado: (2022)

Epstein-Barr Virus Provides a New Paradigm: A Requirement for the Immediate Inhibition of Apoptosis
por: Altmann, Markus, et al.
Publicado: (2005)

Characteristics of Epstein-Barr virus activation of human B lymphocytes
Publicado: (1981)

Epstein–Barr Virus-Specific Immune Control by Innate Lymphocytes
por: Münz, Christian
Publicado: (2017)

Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL
por: Liu, Wen-Hsin, et al.
Publicado: (2020)

Persistent Epstein-Barr viral load in Epstein-Barr viral naïve pediatric heart transplant recipients: Risk of late-onset post-transplant lymphoproliferative disease
por: Das, Bibhuti, et al.
Publicado: (2016)

Open chromatin structures regulate the efficiencies of pre-RC formation and replication initiation in Epstein-Barr virus
por: Papior, Peer, et al.
Publicado: (2012)

Epstein-Barr virus genome packaging factors accumulate in BMRF1-cores within viral replication compartments
por: Sugimoto, Atsuko, et al.
Publicado: (2019)

Epstein-Barr virus susceptibility of normal human B lymphocyte populations
Publicado: (1984)

The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980)

BZLF1 Governs CpG-Methylated Chromatin of Epstein-Barr Virus Reversing Epigenetic Repression
por: Woellmer, Anne, et al.
Publicado: (2012)

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo
por: Murer, Anita, et al.
Publicado: (2019)

CpG-Methylation Regulates a Class of Epstein-Barr Virus Promoters
por: Bergbauer, Martin, et al.
Publicado: (2010)

Association of tumors having Epstein–Barr virus in surrounding lymphocytes with poor prognosis
por: Yogi, Norikazu, et al.
Publicado: (2022)

A Herpesvirus Specific Motif of Epstein-Barr Virus DNA Polymerase Is Required for the Efficient Lytic Genome Synthesis
por: Narita, Yohei, et al.
Publicado: (2015)

SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTES : II. PRESENCE OF EPSTEIN-BARR VIRUS RECEPTORS ON B LYMPHOCYTES
por: Jondal, Mikael, et al.
Publicado: (1973)

Epstein - Barr virus Pneumonitis
por: McManus, Terence E, et al.
Publicado: (2009)

Epstein–Barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015)

Epstein-Barr virus and skin
por: Sangueza-Acosta, Martin, et al.
Publicado: (2018)

Epstein-Barr Virus Gastritis
por: Oki, Masayuki, et al.
Publicado: (2017)

Resurrecting Epstein–Barr Virus
por: Paganelli, Roberto
Publicado: (2022)

The biology of circulating B lymphocytes infected with Epstein-Barr virus during infectious mononucleosis.
por: Robinson, J. E.
Publicado: (1982)

Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10
Publicado: (1993)

Epstein-Barr virus infection and chronic lymphocytic leukemia: a possible progression factor?
por: Dolcetti, Riccardo, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ecojr5c4jsa5hrp2rtnud57knu